Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fixed Dose Combination Tablets”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00399711
What this trial is testing

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 560
Early research (Phase 1)Study completedNCT06719570
What this trial is testing

Doravirine and Islatravir as a Single Entity or Combination Therapy and the Effect of Food in Healthy Adult Participants (MK-8591A-055)

Who this might be right for
Healthy
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Study completedNCT02865668
What this trial is testing

Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 44
Early research (Phase 1)Study completedNCT00934323
What this trial is testing

Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg

Who this might be right for
Healthy
Handok Inc. 33
Early research (Phase 1)Study completedNCT02010944
What this trial is testing

Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

Who this might be right for
Phase 1BioavailabilityHealthy Subjects
Astellas Pharma Europe B.V. 72
Early research (Phase 1)Study completedNCT07396844
What this trial is testing

The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers

Who this might be right for
HealthyFastingFed
LG Chem 28
Early research (Phase 1)Study completedNCT00844207
What this trial is testing

Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine

Who this might be right for
Malaria
Pfizer 40
Early research (Phase 1)Study completedNCT03467945
What this trial is testing

Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants

Who this might be right for
Healthy
Merck KGaA, Darmstadt, Germany 40
Early research (Phase 1)Study completedNCT01581931
What this trial is testing

Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets

Who this might be right for
Healthy
Boehringer Ingelheim 32
Early research (Phase 1)Study completedNCT01755494
What this trial is testing

A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration

Who this might be right for
Type 2 Diabetes Mellitus(T2DM)
AstraZeneca 64
Early research (Phase 1)Study completedNCT02581553
What this trial is testing

Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

Who this might be right for
Healthy
Ardea Biosciences, Inc. 116
Early research (Phase 1)Study completedNCT01844531
What this trial is testing

Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets

Who this might be right for
Healthy
Boehringer Ingelheim 24
Large-scale testing (Phase 3)Study completedNCT00267943
What this trial is testing

Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients

Who this might be right for
Hypertension
Boehringer Ingelheim 639
Not applicableStudy completedNCT01306318
What this trial is testing

A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperisone Hydrochloride 50mg Plus Diclofenac Sodium 50mg as Capsule With Eperisone Hydrochloride 50mg and Diclofenac Sodium 50mg Tablets Under Fasting Conditions (Study 013-10)

Who this might be right for
Healthy Volunteers
Eisai Co., Ltd. 24
Early research (Phase 1)Study completedNCT02084082
What this trial is testing

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 68
Early research (Phase 1)Study completedNCT05535959
What this trial is testing

Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 16
Early research (Phase 1)Study completedNCT01156246
What this trial is testing

Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers

Who this might be right for
Healthy
AstraZeneca 18
Early research (Phase 1)Study completedNCT02259803
What this trial is testing

Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 30
Early research (Phase 1)Study completedNCT02170675
What this trial is testing

Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 24
Early research (Phase 1)WithdrawnNCT01305551
What this trial is testing

BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States

Who this might be right for
Type 2 Diabetes
AstraZeneca
Next Page